Michael Schneiders - Net Worth and Insider Trading
Michael Schneiders Net Worth
The estimated net worth of Michael Schneiders is at least $0 dollars as of 2024-11-07. Michael Schneiders is the Board of Directors of BRAIN Biotech AG and owns about 0 shares of BRAIN Biotech AG (XTER:BNN) stock worth over $0. Details can be seen in Michael Schneiders's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael Schneiders has not made any transactions after 2022-10-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael Schneiders
Michael Schneiders Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael Schneiders owns 1 companies in total, including BRAIN Biotech AG (XTER:BNN) .
Click here to see the complete history of Michael Schneiders’s form 4 insider trades.
Insider Ownership Summary of Michael Schneiders
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
XTER:BNN | BRAIN Biotech AG | 2022-10-11 | Board of Directors |
Michael Schneiders Latest Holdings Summary
Michael Schneiders currently owns a total of 1 stock. Michael Schneiders owns 0 shares of BRAIN Biotech AG (XTER:BNN) as of October 11, 2022, with a value of $0.
Latest Holdings of Michael Schneiders
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
XTER:BNN | BRAIN Biotech AG | 2022-10-11 | 0 | 2.56 | 0 |
Holding Weightings of Michael Schneiders
Michael Schneiders Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael Schneiders has made a total of 3 transactions in BRAIN Biotech AG (XTER:BNN) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in BRAIN Biotech AG is the acquisition of 1,000 shares on October 11, 2022, which cost Michael Schneiders around $4,896.
Insider Trading History of Michael Schneiders
- 1
Michael Schneiders Trading Performance
GuruFocus tracks the stock performance after each of Michael Schneiders's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael Schneiders is 20.06%. GuruFocus also compares Michael Schneiders's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael Schneiders within 3 months outperforms 3 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael Schneiders's insider trading performs compared to the benchmark.
Performance of Michael Schneiders
Michael Schneiders Ownership Network
Ownership Network List of Michael Schneiders
Ownership Network Relation of Michael Schneiders
Michael Schneiders Owned Company Details
What does BRAIN Biotech AG do?
Who are the key executives at BRAIN Biotech AG?
Michael Schneiders is the Board of Directors of BRAIN Biotech AG. Other key executives at BRAIN Biotech AG include Supervisory Board Dr. Michael Majerus , Supervisory Board Dr. Georg Kellinghusen , and Board of Directors Adriaan Moelker .
BRAIN Biotech AG (XTER:BNN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of BRAIN Biotech AG (XTER:BNN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of BRAIN Biotech AG (XTER:BNN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
BRAIN Biotech AG (XTER:BNN)'s detailed insider trading history can be found in Insider Trading Tracker table.
BRAIN Biotech AG Insider Transactions
Michael Schneiders Mailing Address
Above is the net worth, insider trading, and ownership report for Michael Schneiders. Currently GuruFocus does not have mailing address information for Michael Schneiders.